ML18218A515
| ML18218A515 | |
| Person / Time | |
|---|---|
| Site: | 03009938 |
| Issue date: | 07/31/2018 |
| From: | Janice Nguyen Division of Nuclear Materials Safety I |
| To: | Prospect Rockville Hospital, Rockville General Hosp |
| References | |
| 608639 | |
| Download: ML18218A515 (3) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 25 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s}
and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. Prospect Rockville Hospital, Inc. d/b/a The Rockville General Hospital Incorporated
- 2. 31 Union Street Vernon, CT 06066 In accordance with letter dated April 23, 2018. 4. Expiration Date: November 30, 2021 1-------------~
- 5. Docket No.: 030-09938
- 3. License number: 06-13001-02 is amended in its entirety to read as follows: Reference No.: 6. Byproduct.
source, and/or special nuclear material 7. Chemical and/or physical form 8. Maximum amount that licensee 9. Authorized use may possess at any one time under this license A. Any byproduct material A. Any A. As Needed A. For use in uptake, dilution and permitted by 10 CFR excretion studies permitted by 10 CFR 35.100 35.100. B. Any byproduct material B. Any B. As Needed B. For use in imaging and localization permitted by 10 CFR studies permitted by 10 CFR 35.200. 35.200 CONDITIONS
- 10. Licensed material may be used or stored at the licensee's facilities located at 31 Union Street, Vernon, Connecticut.
- 11. The Radiation Safety Officer (RSO) for this license is Edward G. Denstman, M.D ..
NRC FORM 374A MATERIALS LICENSE SUPPLEMENTARY SHEET U.S. NUCLEAR REGULATORY COMMISSION License Number 06-13001-02 Amendment No. 25 Docket or Reference Number 030-09938
- 12. Licensed material shall only be used by, or under the supervision of: A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.14. B. The following individuals are authorized users for the material and medical uses as indicated:
Authorized Users Alok Azad Anand, M.D. Edward G. Denstman, M.D. Thomas Kilkenny, M.D. Gary W. Kravetz, M.D. Vinay Madan, M.D. Ted Stuart Metzger, M.D. Edward M. Rosenblatt, M.D. Fredrick J. Shuler, M.D. Christopher A. Taubes, M.D. Material and Use 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 10 CFR 35.100, 10 CFR 35.200 PAGE 2 OF 3 PAGES 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 06-13001-02 Amendment No. 25 Docket or Reference Number 030-09938
- 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accordance with the regulations.
Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.
A. Application dated June 24, 2011[ML 111790143]
- 8. Letter dated November 21, 2011[ML 113260397]
C. Letter dated June 6, 2016 [ML 16159A358]
D. Letter dated September 29, 2016 [ML 16274A110]
E. Letter dated February 17, 2017 [ML 17060A564]
Date: July 31, 2018 FOR THE U.S. NUCLEAR REGULATORY COMMISSION By~,r}~ J~ Region 1